Antihypertensive Therapy in Patients With Comorbidities

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-01

Study Completion Date

2021-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A retrospective analysis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Analysis of Antihypertensive Treatment Efficacy

NCT00767247

Arterial Hypertension

TERMINATED

Guidelines for Drug Therapy of Hypertension: Closing the Loop

NCT00012636

Hypertension

COMPLETED NA

Registry of Arterial Hypertension

NCT04160533

Arterial Hypertension

UNKNOWN

The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis

NCT01703780

Hypertension, Resistant to Conventional Therapy

UNKNOWN

Pharmacogenomic Evaluation of Antihypertensive Responses 2

NCT01203852

Hypertension

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This retrospective study will be performed using all-Russian nationwide database of anonymized medical health claims and administrative data. The database holds information on diagnoses, patient data, medications, results of examinations, laboratory values, and genomic information, visits, follow up and outcomes. Participating health care organizations include a mix of hospital, primary care, and specialty treatment providers spanning a wide range of geographies, age groups, and income levels.

This study will analyze of outcomes according to comorbidity and antihypertensive drug prescriptions. The study will include patients who were first diagnosed with hypertension, attended the hospital as an outpatient due to hypertension, and received their antihypertensive prescription as an outpatient. To be eligible for inclusion, patients must have had comorbidities and outpatient visits or hospitalizations (for any indication) during the 3-years. The study will focused on comorbidities for choice of antihypertensive drug therapy: diabetes mellitus, dyslipidemia, gout/hyperuricemia, heart diseases, cerebrovascular diseases, and renal diseases.

We going to analyze the EMR of patients who had hypertension and comorbidities by CDSS (MedicBK) utilizing a core laboratory.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adherence to Personalized EBM Antihypertensive Drug Prescriptions for Patients With Hypertension and Comorbidities in Everyday Clinical Practice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

By CDSS (MedicBK) Analysis

antihypertensive therapy

Intervention Type DRUG

Personalized evidence-based antihypertensive therapy in patients with comorbidities

General practice

antihypertensive therapy

Intervention Type DRUG

Personalized evidence-based antihypertensive therapy in patients with comorbidities

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.